Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
Condition(s):Colorectal Cancer; Neoplasm MetastasisLast Updated:February 9, 2009Terminated
Hide Studies Not Open or Pending
Condition(s):Colorectal Cancer; Neoplasm MetastasisLast Updated:February 9, 2009Terminated
Condition(s):Solid Tumor, AdultLast Updated:September 21, 2023Terminated
Condition(s):Multiple MyelomaLast Updated:March 15, 2013Completed
Condition(s):Colorectal NeoplasmsLast Updated:February 23, 2022Recruiting
Condition(s):Kidney CancerLast Updated:October 4, 2023Completed
Condition(s):Esophagus Cancer; Bladder Cancer; Liver Cancer; Ovarian Cancer; Small-cell Lung CancerLast Updated:February 13, 2024Recruiting
Condition(s):Kidney Cancer Stage Iv; Advanced MelanomaLast Updated:September 30, 2020Unknown status
Condition(s):Cancer of Unknown PrimaryLast Updated:April 20, 2022Recruiting
Condition(s):NeuroblastomaLast Updated:May 27, 2021Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:February 20, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.